Carlsmed

Carlsmed

Yahoo Finance • 3 days ago

Goldman Sachs adds 2 stocks to European Conviction List

Investing.com -- Goldman Sachs added Deutsche Bank and Carlsberg to its European Conviction List in its November update, removing HSBC, Haleon and CTP. Still guessing which stocks will beat the market? Our AI portfolio updates monthly and... Full story

Yahoo Finance • 2 months ago

Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical

Carlsmed CARLSBAD, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) ("Carlsmed" ), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today filed a patent infringement lawsuit... Full story

Yahoo Finance • 6 months ago

Carlsmed raises FY 2026 revenue outlook to $72M-$77M as CMS proposes new MS-DRGs for aprevo lumbar

Earnings Call Insights: Carlsmed (CARL) Q1 2026 MANAGEMENT VIEW * "We delivered strong revenue of $16.1 million, representing growth of 58% over the prior year." (Co-Founder, Chairman, CEO & President Michael Cordonnier) * "Operation... Full story

Yahoo Finance • 7 months ago

Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference

CARLSBAD, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 25th Annual Needham Virtual Conference on... Full story

Yahoo Finance • 8 months ago

Carlsmed Unveils Personalized Spine Platform, Targets $70M-$75.5M 2025 Revenue at Conference

Carlsmed logo Key Points aprevo Technology Platform delivers patient-specific 3D surgical planning, on‑demand 3D‑printed implants and sterile single‑use instruments across the pre/intra/post‑op workflow; the company has expanded into cer... Full story

Yahoo Finance • 8 months ago

Carlsmed targets $70M–$75M 2026 revenue with cervical and bilateral product launches amid 44% growth outlook

Earnings Call Insights: Carlsmed, Inc. (CARL) Q4 2025 MANAGEMENT VIEW * CEO Michael Cordonnier reported, "2025 was a rapid growth year for Carlsmed and I could not be prouder of what our team has accomplished to advance our mission of... Full story

Yahoo Finance • 9 months ago

Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

CARLSBAD, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its fourth quarter and full year 2... Full story

Yahoo Finance • 11 months ago

Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting

CARLSBAD, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the U.S. commercial launch of its aprevo® Technology Platform for cervical fusion surgeries. Surgeons involv... Full story

Yahoo Finance • 11 months ago

European beverage stocks trades at deep discounts

Investing.com -- European beverage stocks will enter 2026 offering broad valuation appeal after another year of weak share price performance, though the sector remains cheap for a reason and will require clearer delivery on earnings to unl... Full story

Yahoo Finance • 12 months ago

Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference

CARLSBAD, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and CEO of Carlsmed, will be presenting at the 37th Annual Piper Sandler Heal... Full story

Yahoo Finance • 12 months ago

Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance

Third quarter revenue of $13.1 million, representing 98% growth YoY Raising full year 2025 revenue guidance to $49 million - $50 million CARLSBAD, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or t... Full story

Yahoo Finance • last year

Carlsberg (CPSE:CARL B): Exploring Value After Recent Share Price Dip

Carlsberg (CPSE:CARL B) shares have quietly shifted over the past month, down nearly 4%. This recent move invites a closer look at how the company is performing in today's evolving beverage market. See our latest analysis for Carlsberg.... Full story

Yahoo Finance • last year

How Carlsberg's UK Soft Drinks Expansion With PepsiCo Has Changed Its Investment Story (CPSE:CARL B)

Carlsberg Britvic, in partnership with PepsiCo, recently announced an exclusive UK distribution agreement for Poppi, a US prebiotic soda brand, and is exploring further portfolio expansion with Mexican-style beer and functional soft drinks... Full story

Yahoo Finance • last year

Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary

CARLSBAD, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced the appointment of... Full story

Yahoo Finance • last year

Carlsmed joins Russell 2000 Index following Q3 IPO

* Carlsmed (NASDAQ:CARL [https://seekingalpha.com/symbol/CARL]) added to the Russell 2000 Index effective after market close on September 22, 2025. * Inclusion follows Carlsmed’s IPO in July 2025, part of Q3 index rebalancing. * Sour... Full story

Yahoo Finance • last year

Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index

CARLSBAD, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that effective aft... Full story

Yahoo Finance • last year

Here’s Goldman Sachs’ Next S&P 500 Target — Plus 2 Top Stock Picks

The stock markets are at record highs, having shown a solid recovery from their sharp losses in April. Year-to-date, the S&P 500 is up 11% and the NASDAQ is up 13.5%, reflecting continued positive sentiment. Elevate Your Investing Strateg... Full story

Yahoo Finance • last year

Carlsberg (CPSE:CARL B): Exploring Valuation After Recent Quiet Share Price Drift

Carlsberg (CPSE:CARL B) has been on the radar lately as its shares have drifted lower in recent weeks, even though there has been no headline-grabbing event to drive the moves. Sometimes, it is the subtle shifts that spark the biggest ques... Full story

Yahoo Finance • last year

Carlsmed, Inc. Q2 Sales Increase

(RTTNews) - Carlsmed, Inc. (CARL) released Loss for second quarter of -$6.77 million The company's earnings totaled -$6.77 million, or -$1.47 per share. This compares with -$6.28 million, or -$1.55 per share, last year. The company's re... Full story

Yahoo Finance • last year

UPDATE - Carlsmed® Reports Second Quarter 2025 Financial Results

Q2’25 revenue of $12.1 million, 99% YOY growth Full year revenue guidance of $45.5M - $47.5M CARLSBAD, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company... Full story